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Lymphatic ﬁlariasis is a vector borne parasitic disease causing long term disability. The Global Programme to Eliminate Lymphatic
Filariasis aims to achieve its objective through two strategies; Mass Drug Administration (MDA) to interrupt transmission and
Morbidity Management (MM) to manage disability for those already aﬀected. MDA is going on in full swing in endemic areas; but
MM is lagging behind. An exploratory study was conducted in Pondicherry through focus group discussions to ﬁnd out whether
there are delivery issues if any, in the MM programme and get suggestions from end users. The study results show that MM has not
received the same attention as MDA and there are shortcomings in the delivery mechanism of the programme. The importance of
these ﬁndings are discussed and suggestions given for improving the programme.
1.Introduction
Lymphatic ﬁlariasis (LF) a vector-borne, chronically disa-
bling parasitic infection causing elephantiasis, lymphoede-
ma, and hydrocele, is a major public health problem [1, 2]a s
well as a serious socioeconomic problem due to its morbid
condition, social stigma, and considerable economic loss in
many developing countries [3, 4], and this disease has been
ranked as the second leading cause of long-term chronic
disability worldwide [5]. The disability caused renders those
aﬄicted unproductive and unable to contribute to national
and their individual economic progress [6]. In the year
1997, following advances in diagnosis and treatment, the
World Health Organization (WHO) identiﬁed lymphatic
ﬁlariasisaspotentiallyeradicableoreradicable,leadingtothe
launching of the Global Programme to Eliminate Lymphatic
Filariasis (GPELF) in the year 2000 [6, 7]. According to the
Global Alliance to Eliminate Lymphatic Filariasis (GAELF),
a public-private partnership was created in 2000 to assist in
advocacy,resourcemobilisation,andprogrammeimplemen-
tation. As there are many diﬀerent presentations of clinical
disease related to LF, there is no single drug or treatment
t h a ti se ﬀective for all cases, and therefore three issues should
be considered for all patients (1) antiparasitic drug therapy,
(2) supportive clinical care, and (3) patient education and
counseling [8]. Thus the LF elimination programme aims to
achieve its objective using a twofold strategy of interrupting
transmission with repeated annual rounds of Mass Drug
Administration (MDA) and Morbidity Management (MM)
for those already infected, to prevent/manage disabilities [9].
As a signatory to 50th World Health Assembly resolution
on global elimination of lymphatic ﬁlariasis, India launched
arevisedﬁlariasiscontrolprogramin1997[10].Accordingly,
the National Health Policy 2002 set its aim to eliminate lym-
phaticﬁlariasisby2015andentrustedthetasktotheNational
Vector Borne Disease Control Programme (NVBDCP), the
central nodal agency for the prevention and control of vector
borne diseases in the country. The NVBDCP aims to achieve
this objective using the strategy of MDA of anti ﬁlarial drugs
(diethylcarbamazine (DEC)+Albendazole), for 5 years or
more to the population excluding children below two years,
pregnant women, and seriously ill persons in aﬀected areas
to interrupt transmission of disease and self management of
lymphoedema with limb hygiene [11] and hydrocelectomy2 The Scientiﬁc World Journal
operations in identiﬁed Community Health Centres (CHCs)
and hospitals [12]. Of the twin components of GPELF, MDA
is in operation through national programs in 51 of the
world’s 81 LF endemic countries, but MM has been initiated
only in 27 out of the 81 endemic countries [13]. About 40
million people who already have the disease are yet to be
covered by the programme [14]. Since providing care for
persons who suﬀer from the major forms of ﬁlariasis-related
morbidity is a major goal of GPELF [15], and because recent
studies oﬀer hope to chronic LF patients by proving that, by
following the simple lymphoedema management measures,
morbidity due to LF can be reduced within a period as short
as 4.5 months [16], it is important to address the problems
aﬀecting this programme.
This study is an attempt to explore whether there are
delivery issues if any that are dragging the programme
behind and get suggestions from end users to get maximum
beneﬁt from the programme. The study speciﬁcally exam-
ined three aspects: awareness of the MM programme, prac-
tice of MM, and beneﬁts gained from the MM programme.
It is intended that this research will provide information
necessarytoaddresstheloopholesandprovidesuggestionsto
make the programme responsive to the need of LF patients.
2. Methods
2.1. Study Settings. The study was conducted in the months
of April-May 2009, at two Anganwadis (Anganwadis are
government-sponsored child-care centres serving as day care
and preschools for children of ages 0–6). in Kombakkam
(rural area) and Mudaliarpet (urban area) coming within
the limits of Murugampakkam Primary Health Centre;





temperature is 24◦C[ 19]. The study area is known to be
endemic for ﬁlariasis [20]. Men and women diagnosed with
chronic lymphoedema due to lymphatic ﬁlariasis, living in
the two study areas, and belonging to the age group of
15–60, were purposively selected from the list of ﬁlariasis
patients identiﬁed through line listing by the State Filaria
Control Unit (SFCU) of Pondicherry for morbidity man-
agement, as part of the national programme for elimination
of ﬁlariasis for the study. Purposive sampling helped to
ensure diversity in terms of age, marital status, education,
rural/urban diﬀerence, and socioeconomic background of
participants. Majority of the study participants in the rural
area were agricultural labourers, and others included ﬂower
vendors, house wives, and people who did not perform
any occupation. Among the participants from the urban
area, majority were casual labourers; some were daily wage
workers in private companies, some were retired persons,
some were house wives, and one was a priest. Majority of
the participants from the rural area did not have formal
education where as majority from the urban area had formal
education ranging from primary level to high school level.
2.2. Study Designs and Data Collection. This study was
exploratory in nature, and data was collected through focus
group discussion method. Eight focus group discussions
(four for men and four for women in two PHC areas) were
conducted with 6–10 persons in each group. The discussions
lasted from 60 to 80 minutes and were held around 6 O’clock
in the evening in the premises of two Anganwadis in the
locality, a convenient place for local people to assemble in
the evening after a day’s work. All the discussions were
conducted following the standard procedures for conducting
focus group discussions consisting of a team with a mod-
erator to guide the discussion, a rapporteur to record the
discussion, and two assistants for general arrangements. A
sociologist with research and ﬁeld experience moderated the
discussions.
The study had the approval of the Vector Control
Research Centre’s (VCRC) Institutional Human Ethics Com-
mittee, and informed written consent was obtained from
each participant who took part in the focus group discus-
sions. The participants were informed that the discussion
may last approximately one hour and that, the team will
be taking notes and tape recording the discussion, so that
whatever the participants said would not be missed. Par-
ticipation was voluntary and conﬁdentiality of the opinions
raised by the participants was assured. The discussions were
audiotaped as well as written down by the rapporteur. The
discussion focused on aspects related to present treatment
source, reasons for opting that particular source of treat-
ment, awareness of the MM Programme, their practice of
leg hygiene, improvement due to leg hygiene, opinion about
the programme, suggestion if any for improvement of the
programme, and change in perception about leg hygiene
after attending the focus group discussion.
2.3.DataAnalysis. Theconversationsduringthefocusgroup
discussions were translated and transcribed into English and
analysed for the trends and patterns that emerged from the
discussions. The awareness of MM, practice of MM, and
beneﬁt gained from MM were identiﬁed and given codes.
The codes were then categorised, and the emerging themes
were found out.
3. Results
The following themes emerged from the focus group discus-
sions




(ii) Clinicians and health workers did not seem to be
aware of the new strategies of morbidity manage-
ment.
(iii) Morbidity management programme lacked adequate
publicity in endemic areas.
(iv) Leg hygiene demonstration camps were conducted
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(v) Training on leg hygiene was given only to a small
proportion of the identiﬁed cases.
(vi) The camps demonstrated leg hygiene but failed to
eﬀectively communicate its beneﬁts.
(vii) Only those who knew about the beneﬁts of leg
hygiene through some source practiced it; others
consideredwashingthelegduringbathwassuﬃcient.
(viii) Those who practiced leg hygiene-reported signs of
improvement.
3.2. Other Themes Related to Filariasis Morbidity.
(i) Restricted mobility due to oedema and pain aﬀects
treatment seeking.
(ii) Dueto problemsin mobility, patients hesitate to avail
treatment from distant and crowded places
(iii) Patients in the urban area considered the SFCU clinic
at Saram a very convenient treatment source for
them.
They could take regular treatment because of the
SFCU clinic.
(iv) LF patients in rural areas found it diﬃcult to access
the SFCU clinic
Therefore, they took treatment only during ADL
attacks.
(v) Chronic lymphoedema patients, who did not per-
ceive any improvement in their condition even after
prolonged treatment, gradually stopped treatment.
(vi) Perception of the participants regarding the impor-
tance of leg hygiene changed after the focus group
discussion.
3.3. Patient’s Suggestion Regarding Morbidity Management
Programme. The patients were asked to give their sugges-
tionsforimprovingtheMMprogramme.Thefollowingwere
their suggestions.
(i) MM programme should be given wide publicity and
advertisement.
(ii) Leg hygiene and exercises should be demonstrated
with prior notice at more accessible places like PHCs
or Anganwadis, at a convenient time for casual
labourers and agricultural workers who leave their
homes early in the morning and return late in the
evening.
(iii) Health talk should be given by an expert before
demonstrating leg hygiene, emphasizing its impor-
tance in controlling ADL attacks and slowing down
disease progression.
(iv) Not only chronic cases, patients with lower grades
of lymph oedema also should be covered under the
programme and made aware of the importance of leg
hygieneincontrollingADLattacksandslowingdown
disease progression.
(v) A relative of the patient may also be permitted to
attend the leg hygiene demonstration camp so that
the family members can motivate or help the patient
in maintaining leg hygiene.
4.Results inDetail
Thethemesthatemergedfromthestudyaredescribedbelow.
4.1. Patients Were Not Aware of the Morbidity Management
Programme. Participants in the urban area as well as the
rural area were not aware of the MM programme nor the
camps meant for demonstrating leg hygiene and exercises to
the patients. Clinicians and health workers also did not seem
to be aware of the new strategies of morbidity management
for LF. This was evident from the fact that clinicians and
health workers gave only a routine advice to keep the legs
clean, as reported by the patients.
4.2. Morbidity Management Camps Failed to Convey the
Message That Leg Hygiene Could Prevent ADL Attacks and
Control Disease Progression. Among the participants from
the urban and rural areas, only one person from the urban
area had attended a morbidity management demonstration
camp organised by the PHC in the locality, to promote leg
hygiene. Though he attended the demonstration camp, he
got the impression that it was just another routine advice
for maintaining cleanliness and did not consider it very
important to practice it. The camp could not convey the
idea that leg hygiene can prevent ADL attacks and control
disease progression. Therefore, demonstration classes should
be planned and organised in consultation with experts, well
conversant in communicating with the community.
4.3. Morbidity Management Programme Lacked Adequate
Publicity. It was understood that publicity about MM was
limited to house visits by health workers. There were no
posters, banners, or announcements with public addressing
systems. The ﬁlariasis patients were mostly from poor
economic background, performing agricultural activities, or
engaged as casual labourers. These labourers leave their
homes early in the morning and return late in the evening.
Their houses would be locked during day time when
the health workers visit their houses. Information passed
through house visits was not suﬃcient to reach all the LF
patients.
4.4.LFPatientsConsideredthatCleaningtheLegsduringDaily
Bath Was Suﬃcient. While discussing about their current
practice of leg hygiene, majority of the participants said that
they washed their legs when they took bath and considered
that, was enough. The participants regularly attending the
SFCUclinicsaidthat,thechronicpatientswithhighergrades
of lymphoedema were advised to keep their legs clean. But
they were not told anything about the importance of leg
hygiene in preventing ADL attacks or slowing down the
disease progression.4 The Scientiﬁc World Journal
4.5. Some Patients Knew the Beneﬁt of Leg Hygiene from Other
Sources. Thoughmajorityoftheparticipantsfromtheurban
as well as rural areas were not aware of MM programme,
there were some respondents from the urban area who
knew about leg hygiene and simple exercises for LF. It was
understood that they were participants of a research project
ofVCRCtoassesstheimpactofleghygieneonlymphoedema
volume, skin thickness, and physical disability in patients
withﬁlariallymphoedema.Thesepatientsweretrainedinleg
hygiene according to standard guidelines.
4.6. Those Who Practiced Limb Hygiene Reported Improve-
ment. Though very visible changes could not be observed in
the size of the oedema within a short period, the few who
were practicing leg hygiene for the past one year reported
changes which seem to be encouraging and could be clear
signs of improvement in the long run. Frequency of ADL
had reduced, the skin had become soft, ﬂexibility of limbs
had improved, and domestic activities had become easier for
them.
4.7. Restricted Mobility due to the Disease Aﬀects Treatment.
Higher grades of lymphoedema and hydrocele considerably
restrict the mobility of lymphatic ﬁlariasis patients. They
have diﬃculty in walking long distances, climbing staircases,
riding bicycles, or travelling in the crowded public transport
systemstoreachtreatmentcentres,waitthereinlongqueues,
andavailtimelytreatment.Forsomepatients,theﬁrstoccur-
rence of lymphoedema itself was associated with a long-
distancetravel.Policymakersandprogrammemanagersmay
considertherestrictedmobilityfactorofLFpatientsseriously
in any future course of action for LF patients.
4.8. Filariasis Clinics Are the Preferred Treatment Source but
Are Not Accessible to All LF Patients. Government hospitals
are always crowded and necessitate the patients to stand for
long hours in queues to see the doctor and get medicines.
For an LF patient, continuous standing triggers oﬀ pain and
increase in oedema. Private hospitals are too expensive, and
majority of the LF patients who are from poor economic
background cannot aﬀord to seek treatment there. Because
of these reasons, LF patients prefer to seek treatment from
ﬁlariasis clinics. But in Pondicherry there are only two
ﬁlariasis clinics, one is the ﬁlariasis clinic run by the SFCU,
Pondicherry, and the other is the biweekly ﬁlariasis clinic run
by the VCRC, Pondicherry. The SFCU clinic is situated at
Saram in the city, and VCRC clinic is situated at Gorimedu, a
place 5km away from the city near the Chennai-Dindivanam
road. LF patients in the city make use of these facilities,
but patients in rural areas ﬁnd it diﬃcult to reach them.
Provision of more ﬁlariasis clinics in rural areas or providing
ﬁlariasis clinics attached to the PHCs may help the LF
patients to access timely treatment.
4.9. Patients in Urban Area Took Regular Treatment While
Patients in Rural Areas Took Treatment Only during ADL
Attack. In order to prevent ADL attacks and disease pro-
gression, LF patients are advised to be on regular treatment.
The SFCU clinic provides medicines for one month and
advise the patient to follow up the treatment every month.
People in the urban area were taking regular treatment for
ﬁlariasis. They took treatment either from the SFCU clinic or
the biweekly ﬁlariasis clinic run by the VCRC or from both.
Those patients who could not visit either of these clinics
resorted to self-treatment with old prescriptions.
Patients in the rural area took treatment only during
ADL attacks. Whenever there was an ADL attack, they took
treatment from the nearby private clinics. The SFCU clinic
and VCRC clinic were less accessible to these patients since
both were located in the city and functioned on speciﬁc days
in a week.
4.10. Patients, Who Did Not Perceive Any Improvement in
Their Condition, Stopped Treatment. Patients who did not
perceiveanyimprovementintheirconditioninonesystemof
medicine switched over to other systems of medicine. When
they did not ﬁnd any improvement in other systems also,
they ﬁnally gave up treatment altogether.
4.11. Change in Perception of Leg Hygiene. At the end of
eachdiscussionthegroupmemberswereaskedwhethertheir
perception of the need for leg hygiene had changed after
participatinginthefocusgroupdiscussion.Allmemberssaid
that the discussions were very useful. Many respondents said
that, after attending the focus group discussion only, they
came to know how important was leg hygiene and simple
foot exercises for an LF patient.
5. Discussion
Research during the past two decades has thrown more light
into the morbidity aspects of lymphatic ﬁlariasis and paved
the way for the inclusion of MM as one of the components of
the GPELF (TDR, 2005).
However, the study results show that, of the two com-
ponents of GPELF, the morbidity management component
is lagging behind MDA, and there are shortcomings in
the delivery mechanism of the programme. It was found
that patients were not aware of the programme. From the
accounts of the patients, it is understood that, other than a
routine, general advice to keep their legs clean, the clinicians
or the health workers did not inform the patients about the
new strategies of leg hygiene. It should be assumed that the
clinicians and health workers are also not aware of the same.
A study on clinician’s practices related to management of
ﬁlarial adenolymphangitis and lymphoedema in Orissa has
also reported that none of the clinicians interviewed during
their study instantly revealed that they give advice on foot
hygiene as part of lymphoedema management [21]. Another
study on lymphoedema care in Orissa has reported that the
health workers in the PHCs have not received any training
on lymphedema care, except a half-day training session on
drug distribution before the yearly mass drug administration
of the GPELF. Since there were no facilities in the PHCs to
takecareoflymphedemapatients,thestaﬀwereinstructedto
refer them to any hospital [22]. A study in Srilanka has alsoThe Scientiﬁc World Journal 5
reported that neither limb-care methods nor exercise had
been recommended by any clinician, to any of the patients
they interviewed for their study and that patients who do not
ﬁnd any improvement in their condition gradually stopped
taking treatment for ﬁlariasis [23]. A study in Madhya
Pradesh,toreviewtheprogressofMassDrugAdministration
of single dose of di-ethyl-carbamazine (DEC), has reported
that the level of awareness of the morbidity management in
the community was low, and very few subjects with LF, who
were interviewed, could answer the proper method of care.
They observed that training on morbidity management was
given to only a small proportion of the identiﬁed cases [24].
Though some shortcomings have come to light in the
delivery mechanism of the morbidity management pro-
gramme, they can be rectiﬁed with proper planning and
cooperation.Forinstance,sincethePHCshavebeenassigned
the charge of morbidity management, it is logical to enquire
whether the PHCs have the necessary facilities, trained man
power, and additional time to spare apart from its routine
works like immunization, prevention of malnutrition, care
during pregnancy, child birth, postnatal care, treatment of
common illnesses, and so forth. If the PHCs do not have
the above, the feasibility of opening ﬁlariasis clinics attached
to the PHCs in rural areas by the SFCU may be considered
as one of the option. The medical personnel attending
the LF patients in the PHCs and the SFCU may be given
opportunity to learn about new and developing areas in
the ﬁeld of lymphatic ﬁlariasis through Continued Medical
Education (CME). Health workers in the PHCs and SFCU
clinics need to be made aware of the importance of leg
hygiene in preventing ADL attacks and there by slowing
down the progression of lymphoedema. They need to be
trained to demonstrate leg hygiene and exercises to the
patients. Lackofpublicity andadvertisement is animportant
lacuna of the MM programme. Experts in the ﬁeld of
communication and preparation of Information Education
& Communication (IEC) tools should be consulted and
involved while preparing suitable IEC materials for LF
patients who are generally from poor back grounds and are
less educated.
The fact that, even after prolonged treatment, many LF
patients do not perceive any improvement in their condition,
lead us to the assumption that intake of medicines alone
is not suﬃcient to improve the condition of the patient,
but leg hygiene and simple exercises are also essential for
improving the quality of life of the patients. This underlines
theneedtoconsidermorbiditymanagementasanimportant




WHO: World Health Organization
GPELF: Global Programme to Eliminate Lymphatic
Filariasis
GAELF: Global Alliance to Eliminate Lymphatic
Filariasis
MDA: Mass Drug Administration
MM: Morbidity management
NVBDCP: National Vector Borne Disease Control
Programme
DEC: Diethylcarbamazine citrate
CHCs: Community Health Centres
PHC: Primary Health Centre
SFCU: State Filaria Control Unit
VCRC: Vector Control Research Centre
ADL: Adenolymphangitis
CME: Continued Medical Education
IEC: Information Education & Communication
TDR: Tropical Disease Research (WHO).
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